What new GSK cancer deal shows about pharma market
June 02, 2014 at 03:33 AM EDT
The announcement that GlaxoSmithKline is planning to spend $350 million plus to get a slice of a U.K. biotech's cancer drugs has raised eyebrows.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|